Supplementary Figure 1 from A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor–Positive Breast Cancer: The BRACELET-01/PrE0113 Study

Supplementary Figure 1 from A Phase II Randomized Study of Paclitaxel Alone or Combined with Pelareorep with or without Avelumab in Metastatic Hormone Receptor–Positive Breast Cancer: The BRACELET-01/PrE0113 Study

<p>Supplementary Figure 1. CONSORT Diagram.</p>

Saved in:
Bibliographic Details
Main Author: Amy S. Clark (15053473) (author)
Other Authors: Fengmin Zhao (21632230) (author), Paula Klein (21632233) (author), Alberto J. Montero (17741125) (author), Carla Falkson (15038877) (author), Elisa Krill-Jackson (21632236) (author), Kendrith Rowland (21632239) (author), Sagar Sardesai (21632242) (author), Jason Incorvati (21632245) (author), Patrick Dillon (21632248) (author), Antonio C. Wolff (15017274) (author), Richard Trauger (21632251) (author), Thomas C. Heineman (21632254) (author), Matthew C. Coffey (21632257) (author), Kathy D. Miller (15045080) (author)
Published: 2025
Subjects:
Cancer
Immuno-oncology
Clinical Research and Trials
Breast Cancer
Clinical Trial Results
Phase II clinical trials
Immunotherapy
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items